Constarium
← Search

Data · dataset · 2015

Maraviroc intensification of cART in patients with suboptimal immunological recovery: a 48-week, placebo-controlled randomized trial

Listed in DataCite

File: CD38+ HLA-DR+ CD4 and CD8 T cells.

Description

This SPSS file contains the percentage of CD38+ HLA-DR+ CD4 and CD8 T cells at various time points during the MIRS trial. Please see the 'variable view' of the SPSS file and the 'methods' section of the paper for more information.

We have used SAS software for our analyses.

Links

Topics

Stated by source
Health sciences
Provenance · 1 source records, 9 field assertions
SourceKeyLast seenRaw
DataCite10.6084/m9.figshare.143115213 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · DataCiteconnector:datacite@1.0.0/data/attributes/rightsList
byte_sizesource · DataCiteconnector:datacite@1.0.0
concepts[field].fos:health-sciencessource · DataCiteconnector:datacite@1.0.0
created_datesource · DataCiteconnector:datacite@1.0.0
descriptionsource · DataCiteconnector:datacite@1.0.0/data/attributes/descriptions
licensesource · DataCiteconnector:datacite@1.0.0/data/attributes/rightsList
publication_datesource · DataCiteconnector:datacite@1.0.0/data/attributes/dates
titlesource · DataCiteconnector:datacite@1.0.0/data/attributes/titles/0/title
updated_datesource · DataCiteconnector:datacite@1.0.0